Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Cycl2R's Profile
Displaying 401-450 of 571 result(s).
CYDY CytoDyn Inc
07/13/2020 12:03:52 PM
We have the right to know the speci (5)
CYDY CytoDyn Inc
07/13/2020 8:25:09 AM
the FDA is corrupt and making a del (1)
CYDY CytoDyn Inc
07/12/2020 10:40:46 PM
He then remarked that “... this d
CYDY CytoDyn Inc
07/08/2020 5:36:38 PM
Control #? I have CYDY on my 3 acco
CYDY CytoDyn Inc
07/06/2020 8:33:11 PM
The FDA delayed us unnecessarily an (1)
CYDY CytoDyn Inc
07/06/2020 6:14:10 AM
I was thinking couple days ago what
CYDY CytoDyn Inc
07/05/2020 8:20:41 PM
NP has big heart and great business (7)
CYDY CytoDyn Inc
07/05/2020 11:43:40 AM
I don't understand why we need FDA' (2)
CYDY CytoDyn Inc
07/04/2020 10:02:34 AM
the Trump admin said they will anno (7)
CYDY CytoDyn Inc
07/03/2020 2:15:58 PM
Where is the creativity and innovat
CYDY CytoDyn Inc
07/03/2020 11:29:44 AM
"Terrible timing" ______________ CD
CYDY CytoDyn Inc
07/02/2020 10:46:17 AM
Interesting! We have a group of out (9)
CYDY CytoDyn Inc
07/02/2020 8:56:15 AM
Dr. Lalezari: "...very soon we’ll (9)
CYDY CytoDyn Inc
07/01/2020 11:14:43 AM
"Consider owning CYDY as going to W (8)
CYDY CytoDyn Inc
07/01/2020 8:02:29 AM
In our economic system an attack ag (3)
CYDY CytoDyn Inc
06/30/2020 8:38:01 PM
The FBI not SEC should be investiga (1)
CYDY CytoDyn Inc
06/29/2020 10:06:09 AM
Unbelievable strength during this r
CYDY CytoDyn Inc
06/28/2020 11:36:29 AM
A new short attack in preparation?
CYDY CytoDyn Inc
06/27/2020 2:31:27 PM
This new paper in Nature strongly c
CYDY CytoDyn Inc
06/27/2020 10:39:05 AM
Bixellou: "If that's true, those ar (4)
CYDY CytoDyn Inc
06/26/2020 11:28:13 PM
How good do we have to be to get at (5)
CYDY CytoDyn Inc
06/26/2020 10:08:53 AM
"In my heart of hearts this is a ho (3)
CYDY CytoDyn Inc
06/20/2020 1:38:40 PM
I have the time to wait 3/5 years f (1)
CYDY CytoDyn Inc
06/20/2020 9:32:42 AM
New SA piece on CYDY/Covid https:// (3)
CYDY CytoDyn Inc
06/15/2020 5:06:42 PM
I also find it curious that some in (1)
CYDY CytoDyn Inc
06/13/2020 1:01:52 PM
You see our brains are designed to
CYDY CytoDyn Inc
06/13/2020 12:24:14 PM
" Editors of The Lancet and the New (1)
CYDY CytoDyn Inc
06/10/2020 12:44:53 PM
What is the the purpose of your all (1)
CYDY CytoDyn Inc
06/10/2020 9:57:51 AM
Over the last couple of weeks this (7)
CYDY CytoDyn Inc
06/09/2020 11:06:00 AM
Covid-`19 and Leronlimab: A Scienti
CYDY CytoDyn Inc
06/07/2020 9:14:58 AM
Russia approves Levilimab. https:// (1)
CYDY CytoDyn Inc
06/05/2020 8:00:55 PM
Calquence (acalabrutinib) is a kina (1)
CYDY CytoDyn Inc
06/05/2020 2:23:48 PM
I guess this is how a "home run" lo (1)
CYDY CytoDyn Inc
05/29/2020 1:44:23 PM
And it’s ALWAYS been about the $$
CYDY CytoDyn Inc
05/28/2020 9:52:56 AM
I never said we should blame the FD
CYDY CytoDyn Inc
05/28/2020 9:08:10 AM
Just a point, the FDA doesn’t set
CYDY CytoDyn Inc
05/28/2020 8:22:06 AM
Meanwhile, a treatment with ZERO SA (3)
CYDY CytoDyn Inc
05/27/2020 9:26:48 AM
We must remember that this is P2. F (1)
CYDY CytoDyn Inc
05/24/2020 12:42:02 PM
The point is that we are investing (3)
CYDY CytoDyn Inc
05/22/2020 11:19:42 AM
CDiddY wrote: >>Why?, capitalism is (2)
CYDY CytoDyn Inc
05/21/2020 1:04:58 PM
Montefiori has no need in self-prom
CYDY CytoDyn Inc
05/20/2020 9:33:34 PM
Another look on our wonderful FDA a (3)
CYDY CytoDyn Inc
05/20/2020 10:18:05 AM
The inordinate loss of American liv (1)
CYDY CytoDyn Inc
05/14/2020 9:08:11 AM
Paper in NEJM of May 12 mentions le (1)
CYDY CytoDyn Inc
05/13/2020 3:58:23 PM
WOW! The toxicity of these agents a (1)
CYDY CytoDyn Inc
05/12/2020 10:41:41 PM
How is it that the person in charge (5)
CYDY CytoDyn Inc
05/12/2020 8:07:22 AM
COVID-19 clinical trial at Forsyth
CYDY CytoDyn Inc
05/09/2020 6:36:14 AM
Leronlimab Shows Further Promise fo (2)
CYDY CytoDyn Inc
05/08/2020 10:17:29 AM
“It was like I was under water”
CYDY CytoDyn Inc
05/07/2020 12:37:36 PM
Quote: One say, Fauci will say the (1)
Go to page:
  • << First
  • < Previous
  • 8
  • 9
  • Next >

Recent Articles

  • HashJ Expands Accessibility for XRP Investors with New Contracts
  • Trice Contracting Inc. Expands Services for Historic Preservation
  • Revolutionary Weight Loss Pill Offers New Hope for Obesity
  • Exploring the Future of Internet Connectivity with Starlink
  • Seize the Moment: Participate in Reckitt Benckiser Class Action
  • Reckitt Benckiser Securities Fraud Lawsuit Deadline Approaches
  • Therapy Ideas for Your Innovative Health and Wellness Center
  • Meta's Bold Move: Why Investing $250M in AI Talent Matters
  • Accessory Dwelling Unit Plans in 2025: Smart Designs for Purpose, Space & Long-Term Value
  • Impact of Tariff Loophole Elimination on Global Commerce
  • Berkshire Hathaway's $3.8 Billion Write-Down on Kraft Heinz
  • Unveiling Success: President Trump's Achievements This Week
  • Berkshire Hathaway's Caution as Cash Reserves Hit $344 Billion
  • Elon Musk Addresses Control Concerns Amid Shareholder Influence
  • Unlocking Fitness Franchise Opportunities: Your Guide to a Stronger Business Future
  • President Trump’s Vision: Turning America’s Aspirations into Reality
  • Home Sellers Adjust to Buyer Hesitation Amid Price Challenges
  • Two Smart Paths to Franchise Ownership: Medical and Mosquito Control Businesses
  • Investor Alert: Class Actions for Neogen, Alto, RxSight, and Replimune
  • TrimIQ UK Launch: A Revolutionary Approach to Wellness
  • Exploring Arialief: A Natural Solution for Nerve Pain Relief
  • Unlocking the Secrets of No Deposit Free Spins at Wild Casino
  • Sam Altman's Urgent Caution on AI Risks and Innovations
  • Matsato Knife Revolutionizes Culinary Tools in Key Markets
  • Discover the Benefits of Audizen Drops for Nerve Health
  • Niche Matters: How Focusing Drives RIA Growth and Client Loyalty
  • Significant Movement in Bitcoin as Long-Dormant Wallet Empties
  • Reddit Investors: Join the Class Action Against Fraud Today
  • Investor Alert: Securities Fraud Class Action Lawsuit Against Hims & Hers
  • Perplexity's Success: Aravind Srinivas Challenges Tech Titans
  • Insights from Bill Ackman: Investing During Market Uncertainty
  • Berkshire Hathaway Faces Challenges Amidst Market Uncertainty
  • Unveiling Underrated Stocks to Watch for Future Growth
  • Revolutionizing Connectivity: The Future of Starlink Technology
  • Understanding Your Rights as a Simulations Plus, Inc. Investor
  • Shiba Inu Coin Flourishes as HashJ Introduces New Contracts
  • Recent Stock Insights: Key Players in the Market Breakdown
  • Risetcar's Autonomous Taxis Set to Transform Jakarta's Transport
  • Pan-Mass Challenge: Cyclists Unite for Groundbreaking Research
  • Bitcoin Swift Presale Enters New Phase with Innovative AI Rewards
  • Celebrating Financial Health: Global Impact Champions Awards Launch
  • Avast Emerges as the Top Choice for Antivirus Software
  • FAA Implements Changes to Helicopter Routes after Tragedy
  • Navigating High-Beta Stocks: Echoes of the Dot-Com Boom
  • Understanding the Real Dynamics Behind Portfolio Performance
  • Overview of Financière de Tubize’s Half-Year Performance
  • Financière de Tubize Unveils Promising Financial Results for 2025
  • Legal Actions from Shareholders: Insights on Sarepta and Petco
  • Kuvi.ai Unveils Agentic Finance OS in Seed Funding Expansion
  • SHARC Energy Advancing Financing with New Convertible Debentures
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site